3-amino-4H-thieno[3,4-c]chromen-4-one, 90.0%, 250mg

2-Methoxy-4-phenylbenzaldehyde, 96%, 10g

Acide toluène-4-sulfonique monohydraté, min 98 %, pour la synthèse, 500 g, emballage plastique.

7H-PURINE-7-ACETAMIDE, 1,2,3,6-TETRAHYDRO-1,3-DIMETHYL-2,6-DIOXO-N-(6-PHENYL-3-PYRIDAZINYL)-, 98%, 25mg

Tris(2-ethylhexyl)amine; >98%, 93.0%, 25g

6-Hydroxy-1-isopentyl-4-methyl-2-oxo-1,2-dihydropyridine-3-carbonitrile, 98%, 100mg

2-Hydroxy-6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzaldehyde, 96%, 5g

Récipients de réactifs Contenu 100 ml, Stérile, 20 x 5, 100 pièces, 100 pièces

N-methoxy-N,3,5-trimethylbenzamide, 95.0%, 2g

1H-PYRROLE-2,5-DIONE,1,1'-(OXYDI-4,1-PHENYLENE)BIS-, 97.0%, 250mg

Methyl 5-bromo-2-methylnicotinate, 95.0%, 1g

2-AZETIDINECARBOXYLIC ACID,2-METHYL-,METHYL ESTER,HCL, 95.0%, 250mg

2-(2,6-Dioxopiperidin-3-yl)-4-(prop-2-yn-1-ylamino)isoindoline-1,3-dione, 95%, 1g